Ning Ma
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Cancer-related molecular mechanisms research 32
- MicroRNA in disease regulation 28
-
- Heme Oxygenase-1 and Carbon Monoxide 14
- RNA modifications and cancer 14
- Epigenetics and DNA Methylation 13
- Co-authors
- Shosuke Kawanishi (56 shared papers)Yusuke Hiraku (48 shared papers)Mariko Murata (60 shared papers)Somchai Pinlaor (16 shared papers)Qiuhui Hu (39 shared papers)Wenjian Yang (36 shared papers)Fei Pei (30 shared papers)Yong Fang (18 shared papers)
- Journals
- Advances in experimental medicine and biology (14 papers)Postharvest Biology and Technology (9 papers)PLoS ONE (8 papers)Scientific Reports (8 papers)Food Chemistry (7 papers)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Ning Ma
466 papers receiving 17.7k citations
Ning Ma's Hit Papers
Peers
Comparison fields: 5 of 183
- Hepatology 1.4k
- Cancer Research 2.3k
- Biochemistry 515
- Molecular Biology 5.4k
- Oncology 1.9k
Countries citing papers authored by Ning Ma
This map shows the geographic impact of Ning Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Ma more than expected).
Fields of papers citing papers by Ning Ma
This network shows the impact of papers produced by Ning Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Ma. The network helps show where Ning Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Ning Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 484 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma Hit paper breakdown → | 2021 | 1228 |
| 2 | KCNQ1 Gain-of-Function Mutation in Familial Atrial Fibrillation Hit paper breakdown → | 2003 | 815 |
| 3 | Epidemiology of primary Sjögren’s syndrome: a systematic review and meta-analysis Hit paper breakdown → | 2014 | 651 |
| 4 | 2006 | 389 | |
| 5 | 2014 | 380 | |
| 6 | 2015 | 370 | |
| 7 | Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial Hit paper breakdown → | 2023 | 362 |
| 8 | 2004 | 323 | |
| 9 | 2013 | 237 | |
| 10 | 2017 | 224 | |
| 11 | 2018 | 211 | |
| 12 | 2015 | 211 | |
| 13 | 2013 | 193 | |
| 14 | 2015 | 185 | |
| 15 | 2012 | 183 | |
| 16 | 2013 | 173 | |
| 17 | 2019 | 171 | |
| 18 | 2017 | 171 | |
| 19 | 2016 | 170 | |
| 20 | 2021 | 169 |
About Ning Ma
Ning Ma is a scholar working on Cancer Research, Molecular Biology, Immunology, Pharmacology and Oncology, having authored 484 papers that have together received 18.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (32 papers), MicroRNA in disease regulation (28 papers), Fungal Biology and Applications (23 papers), Aldose Reductase and Taurine (20 papers), Heme Oxygenase-1 and Carbon Monoxide (14 papers), RNA modifications and cancer (14 papers), Immune Cell Function and Interaction (13 papers) and Epigenetics and DNA Methylation (13 papers). The work is most often cited by research in Hepatology (1.4k citations), Cancer Research (2.3k citations), Biochemistry (515 citations), Molecular Biology (5.4k citations) and Oncology (1.9k citations). Ning Ma has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Shosuke Kawanishi, Yusuke Hiraku, Mariko Murata, Somchai Pinlaor, Qiuhui Hu, Wenjian Yang, Fei Pei, Yong Fang, Shinji Oikawa and Bao‐Dong Qin. Their work appears in journals such as Advances in experimental medicine and biology, Postharvest Biology and Technology, PLoS ONE, Scientific Reports and Food Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.